ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,155 | -31.0% | 5,900 | -15.0% | 0.00% | – |
Q2 2023 | $46,581 | -24.5% | 6,942 | -0.7% | 0.00% | – |
Q1 2023 | $61,722 | +21.9% | 6,990 | +5.5% | 0.00% | – |
Q4 2022 | $50,638 | -32.5% | 6,628 | -37.3% | 0.00% | – |
Q3 2022 | $75,000 | -73.8% | 10,566 | -70.1% | 0.00% | -100.0% |
Q2 2022 | $286,000 | -57.6% | 35,310 | -27.3% | 0.00% | 0.0% |
Q1 2022 | $674,000 | -50.4% | 48,592 | +0.3% | 0.00% | -50.0% |
Q4 2021 | $1,359,000 | +2.0% | 48,435 | +23.6% | 0.00% | -33.3% |
Q3 2021 | $1,332,000 | -13.1% | 39,202 | +4.5% | 0.00% | 0.0% |
Q2 2021 | $1,533,000 | +38.0% | 37,523 | +35.9% | 0.00% | +50.0% |
Q1 2021 | $1,111,000 | -23.6% | 27,617 | +12.2% | 0.00% | -33.3% |
Q4 2020 | $1,455,000 | +20.2% | 24,608 | -1.1% | 0.00% | 0.0% |
Q3 2020 | $1,210,000 | +9.3% | 24,872 | +8.7% | 0.00% | 0.0% |
Q2 2020 | $1,107,000 | +371.1% | 22,880 | +170.2% | 0.00% | +200.0% |
Q1 2020 | $235,000 | – | 8,468 | +846700.0% | 0.00% | – |
Q4 2019 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |